Drug VAT exemptions seen boosting pharma growth

THE expansion of value-added tax (VAT) exemptions on medicine is expected to improve drug affordability and support the growth of the pharmaceutical industry, according to BMI, a unit of Fitch Solutions. The Bureau of Internal Revenue’s recently-expanded list of VAT-exempt medicines for serious and chronic illnesses brought the total number of exempt products to 2,263. […]